These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2717290)

  • 1. Lavage treatment of distal intestinal obstruction syndrome in children with cystic fibrosis.
    Koletzko S; Stringer DA; Cleghorn GJ; Durie PR
    Pediatrics; 1989 May; 83(5):727-33. PubMed ID: 2717290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung transplantation for cystic fibrosis: 6-year follow-up.
    Quattrucci S; Rolla M; Cimino G; Bertasi S; Cingolani S; Scalercio F; Venuta F; Midulla F
    J Cyst Fibros; 2005 May; 4(2):107-14. PubMed ID: 15914093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrograffin use in distal intestinal obstruction syndrome of cystic fibrosis.
    Shah U; Shafiq Y; Khan MA
    J Ayub Med Coll Abbottabad; 2007; 19(1):58-60. PubMed ID: 17867484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Distal intestinal obstruction syndrome: report of two cases with cystic fibrosis].
    Heine T C; Parada C MT; Gil D R; López K F; Lizana S C; Fernández A M; Quera P R
    Rev Med Chil; 2010 Jan; 138(1):68-72. PubMed ID: 20361153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct assessment of gastrointestinal inflammation and mucosal immunity in children with cystic fibrosis.
    Croft NM; Marshall TG; Ferguson A
    Postgrad Med J; 1996 Mar; 72 Suppl 2():S32-6. PubMed ID: 8869180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of resistant distal intestinal obstruction syndrome with a modified antegrade continence enema procedure.
    Clifton IJ; Morton AM; Ambrose NS; Peckham DG; Conway SP
    J Cyst Fibros; 2004 Dec; 3(4):273-5. PubMed ID: 15698947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oro-caecal transit time and intra-luminal pH in cystic fibrosis patients with distal intestinal obstruction syndrome.
    Dalzell AM; Heaf DP
    Acta Univ Carol Med (Praha); 1990; 36(1-4):159-60. PubMed ID: 2130682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of distal intestinal obstruction syndrome in cystic fibrosis.
    Rosenstein BJ; Langbaum TS
    J Pediatr Gastroenterol Nutr; 1983 May; 2(2):299-301. PubMed ID: 6553601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of medical treatment in an adult cystic fibrosis patient with meconium ileus equivalent.
    Khaitov S; Nissan A; Beglaibter N; Freund HR
    Tech Coloproctol; 2005 Apr; 9(1):42-4. PubMed ID: 15868498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cisapride in patients with cystic fibrosis and distal intestinal obstruction syndrome.
    Koletzko S; Corey M; Ellis L; Spino M; Stringer DA; Durie PR
    J Pediatr; 1990 Nov; 117(5):815-22. PubMed ID: 2231217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constipation and meconium ileus equivalent in patients with cystic fibrosis.
    Rubinstein S; Moss R; Lewiston N
    Pediatrics; 1986 Sep; 78(3):473-9. PubMed ID: 3748682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of distal intestinal obstruction syndrome in cystic fibrosis with a balanced intestinal lavage solution.
    Cleghorn GJ; Stringer DA; Forstner GG; Durie PR
    Lancet; 1986 Jan; 1(8471):8-11. PubMed ID: 2867297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
    Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
    Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twelve-year experience with the Thow long intestinal tube: a means of preventing postoperative bowel obstruction.
    Sprouse LR; Arnold CI; Thow GB; Burns RP
    Am Surg; 2001 Apr; 67(4):357-60. PubMed ID: 11308004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients.
    Colombo C; Ellemunter H; Houwen R; Munck A; Taylor C; Wilschanski M;
    J Cyst Fibros; 2011 Jun; 10 Suppl 2():S24-8. PubMed ID: 21658638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome.
    Correll GE; Maleki J; Gracely EJ; Muir JJ; Harbut RE
    Pain Med; 2004 Sep; 5(3):263-75. PubMed ID: 15367304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.